Acromegaly - Before and After Treatment

Last updated: December 4, 2020
Sponsor: University of Aarhus
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sleep Apnea Syndromes

Sleep Disorders

Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT03431727
1-10-72-126-16
  • Ages > 18
  • All Genders

Study Summary

The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Recently diagnosed with acromegaly
  • Age above 18
  • Written consent

Exclusion

Exclusion Criteria:

  • Pregnancy

Study Design

Total Participants: 20
Study Start date:
October 01, 2017
Estimated Completion Date:
December 01, 2022

Study Description

Acromegaly is a rare disease caused by a growth hormone (GH) producing pituitary adenoma. Surgery is primary treatment, whereas medical treatment with a somatostatin analogue (SA), which suppresses GH secretion and reduces tumour size, is used when surgery is insufficient or unfeasible. Acromegaly is associated with metabolic abnormalities which contributes to an increased morbidity and mortality if left untreated. To which extend these abnormalities reverses after treatment, and if treatment modality influences the outcome, remain elusive. The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment

Connect with a study center

  • Aarhus University Hospital, Department of internal medicine and endocrinologi

    Aarhus, 8000
    Denmark

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.